Leaderboards/complement system in diseases

complement system in diseases

Last updated June 2, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
David S. Roberts
Stanford University
99
2
Ying Ge
University of Wisconsin–Madison
90
3
Jianfeng Feng
Fudan University
70
4
Philipp Reautschnig
University of Tübingen
60
5
Thorsten Stafforst
University of Tübingen
50
6
Fabian J. Theis
Helmholtz Zentrum München
30
7
Alessandro Matera
University of Lausanne
20

Rising Stars Papers

Insufficient data

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Jialin Liu
Sichuan University
99
2
József Dobó
HUN-REN Research Centre for Natural Sciences
90
3
Weijia Wang
Zhongshan People's Hospital
70
4
Jacqui Nimmo
UK Dementia Research Institute
60
5
Gian‐Luca McLelland
The Netherlands Cancer Institute
30
6
Suhail Ahmad Mir
University of Kashmir
20
7
Ahmet Özen
Fakultet za Poslovni Menadžment u Baru
10

Emerging Leaders Papers

1
The Lectin Pathway of the Complement System—Activation, Regulation, Disease Connections and Interplay with Other (Proteolytic) Systems
International Journal of Molecular Sciences|2024
78 cit.
2
Identification of an alternative triglyceride biosynthesis pathway
Nature|2023
77 cit.

All-Time Leaders

The canon

All-Time Leaders Researchers

1
Markus Stoffel
Rockefeller University
99
2
Liangfang Zhang
University of California, San Diego
90
3
Alexander V. Chervonsky
Jackson Laboratory
80
4
Naoto Shibuya
Meiji University
60
5
Jun‐Ichi Hayashi
University of Tsukuba
50
6
Douglas T. Fearon
Johns Hopkins University
40
7
Jay W. Heinecke
University of Washington
30
8
Jeffrey Laurence
Weill Cornell Medicine
20
9
Bart De Strooper
Allen Institute for Brain Science
10

All-Time Leaders Papers

1
Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions.
Journal of Clinical Investigation|1994
1.3k cit.
2
3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima.
Journal of Clinical Investigation|1997
843 cit.
3
Two LysM receptor molecules, CEBiP and OsCERK1, cooperatively regulate chitin elicitor signaling in rice
The Plant Journal|2010
708 cit.
4
Alteration of the microRNA network during the progression of Alzheimer's disease
EMBO Molecular Medicine|2013
476 cit.
5
Presenilins and  -Secretase: Structure, Function, and Role in Alzheimer Disease
Cold Spring Harbor Perspectives in Medicine|2011
461 cit.
6
Presenilin clinical mutations can affect γ‐secretase activity by different mechanisms
Journal of Neurochemistry|2006
410 cit.
7
Depletion of stromal cells expressing fibroblast activation protein-α from skeletal muscle and bone marrow results in cachexia and anemia
The Journal of Experimental Medicine|2013
406 cit.
8
Human neutrophils employ the myeloperoxidase-hydrogen peroxide-chloride system to convert hydroxy-amino acids into glycolaldehyde, 2-hydroxypropanal, and acrolein. A mechanism for the generation of highly reactive alpha-hydroxy and alpha,beta-unsaturated aldehydes by phagocytes at sites of inflammation.
Journal of Clinical Investigation|1997
387 cit.
9
Phenotypic and Biochemical Analyses of BACE1- and BACE2-deficient Mice
Journal of Biological Chemistry|2005
352 cit.
10
The myeloperoxidase system of human phagocytes generates Nε-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation
Journal of Clinical Investigation|1999
348 cit.

Indexing complement system in diseases Reagents

Citation data for reagents in this field is currently compiling.